Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biogen Idec (NQ: BIIB )

149.32 +3.12 (+2.14%)
Streaming Delayed Price Updated: 11:39 AM EST, Jan 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biogen Idec

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
49 50 Next >
With All Eyes On Lecanemab Read Out In Alzheimer's, Uncertainty Overshadows Biogen's Q2 Beat
Via Benzinga
Benzinga Before The Bell: Baidu Beats Tesla, Finland Sells $47.5M Bitcoins, Tesla's Bitcoin Sale And Other Top Financial Stories Thursday, July 21
CNBC 
Via Benzinga
Tesla to $1,175? Here Are 5 Other Price Target Changes for Thursday
Mizuho raised Tesla, Inc. (NASDAQ: TSLA) price target from $1,150 to $1,175. However, Mizuho analyst Vijay Rakesh maintained a Buy rating on the stock. Tesla shares rose 3.3% to $766.88 in pre-market... 
Via Benzinga
Biogen Reveals $900M Settlement In Whistleblower's MS Drug Kickbacks Lawsuit Days Before Trial
Biogen, Inc. (NASDAQ: BIIB) disclosed in its second-quarter earnings report that it recorded $900 million related to a settlemen 
Via Benzinga
Biogen (BIIB) Stock Dips Following Q2 Earnings Report
Biogen delivered a Q2 beat on the top and bottom lines, but a lack of important disclosures is hurting sentiment for BIIB stock. 
Via InvestorPlace
Earnings Beat, Increased FY22 Outlook, Rising Biosimilar Competition: Biogen's Q2 Highlights
Via Benzinga
Recap: Biogen Q2 Earnings
  Biogen (NASDAQ:BIIB) reported its Q2 earnings results on Wednesday, July 20, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022. 
Via Benzinga
Stranger Things Do Happen As Netflix Surprises Investors
(Wednesday Market Open) The European Commission (EU) has asked its 27 member nations to reduce their natural gas consumption by 15% between August and March 2023. The announcement turned U.S. equity... 
Via Benzinga
Biogen Stock Falls Despite Beat-And-Raise Q2 Report
Biogen stock fell early Wednesday after the biotech company reported adjusted profit of $5.25 per share on sales $2.59 billion in Q2. 
Via Investor's Business Daily
The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Biogen Inc. Q2 Earnings And Revenues Surpass Estimates
Biogen Inc. came out with quarterly earnings of $5.25 per share. 
Via Talk Markets
These Biotechs Are Reportedly Reinvigorating Alzheimer's Disease Research With Novel Drugs That Push Beyond Traditional Approaches
More than 55 million people worldwide have dementia — with about 60% to 70% of those cases resulting from Alzheimer’s disease — and that number is expected to triple by 2050. 
Via Benzinga
Investors Turn Their Attention To The Earning Season
US stock indices rose on Tuesday as investors temporarily put aside recession fears and dived into the reporting season. 
Via Talk Markets
Analyst Ratings for Biogen
Analysts have provided the following ratings for Biogen (NASDAQ:BIIB) within the last quarter: 
Via Benzinga
Earnings Scheduled For July 20, 2022
Companies Reporting Before The Bell • Wipro (NYSE:WIT) is projected to report quarterly earnings at $0.08 per share on revenue of $2.80 billion. 
Via Benzinga
Netflix Earnings NFLX In Motion - What Levels are in Play and also for Tesla TSLA Tomorrow?
Netflix reported earnings right after the bell Tuesday and shares surged right on the announcement - but will they hold going into Wednesday morning? 
Via Talk Markets
Apple Upstages Goldman Sachs On Monday, Bringing Rally To A Screeching Halt
(Tuesday Market Open) A big slide in the U.S. dollar appears to be pushing stocks higher Tuesday as a slew of earnings arrived before the opening bell. 
Via Benzinga
Biogen's Earnings Outlook
Biogen (NASDAQ:BIIB) is set to give its latest quarterly earnings report on Wednesday, 2022-07-20. Here's what investors need to know before the announcement. Analysts estimate that Biogen will report... 
Via Benzinga
Tesla, Twitter, Goldman Among Headline Earnings Of Unfolding Week: Here Are The Key Earnings Ahead
The June quarter reporting season is entering its second week, with the focus gradually shifting from banks to technology companies. 
Via Benzinga
Bank Of America And Goldman Sachs Split On Earnings Reports, Possibly Putting Bank Rally In Jeopardy
(Monday Market Open) Investors around the globe appear to be starting the new trading week with a positive attitude as Asian and European markets traded higher overnight helping to boost U.S. equity... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Another Way To Understand Market Momentum
(Friday Market Open) U.S. equity futures moved higher early Friday as investors digested better-than-expected June retail sales data and China’s worst GDP numbers since the start of the pandemic. Later... 
Via Benzinga
Hot Inflation And Earnings Misses Weigh On Equity Futures
(Thursday Market Open) The equity markets may take another hit today as JPMorgan Chase (NYSE: JPM) and Morgan Stanley (NYSE: MS) kicked off a new earnings season with a couple of misses as eq 
Via Benzinga
Looking Into Biogen's Recent Short Interest
Biogen's (NASDAQ:BIIB) short percent of float has fallen 4.95% since its last report. The company recently reported that it has 2.52 million shares sold short, which is 1.73% of... 
Via Benzinga
The Fed's Pickle: Whether to Raise Rates to Fight Inflation While Increasing Recession Chances
(Wednesday Market Open) The June Consumer Price Index (CPI) came in much hotter than expected, and equity index futures tumbled before the open.  
Via Benzinga
Here's How Much You Would Have Made Owning Biogen Stock In The Last 15 Years
Biogen (NASDAQ:BIIB) has outperformed the market over the past 15 years by 3.87% on an annualized basis producing an average annual return of 10.15%. Currently, Biogen has a market capitalization of... 
Via Benzinga
Pliant Therapeutics Stock Just Doubled And Hit A 10-Month High — Here's Why
The company's IPF treatment is proving itself where others didn't. 
Via Investor's Business Daily
The 3 Leaders of the Gene Editing Revolution
There's a wide field of gene editing stocks, but if you're looking for the best opportunities, there are a few likely winners to watch. 
Via InvestorPlace
7 Moonshot Investments Upending a $10 Trillion Industry
Gene editing is expensive at an estimated $5 billion per drug, but it could change the world in the very near future. 
Via InvestorPlace
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.